Dr. Thomas Craig Hammond, MD

Dr. Hammond practices at B.S.S. International, Inc in Tamarac, Florida.

Dr. Hammond's NPI, 1629019799, was assigned on June 9, 2006. Dr. Hammond graduated from New York University School of Medicine in 1975. Dr. Hammond holds Florida license ME38185.

Dr. Hammond's primary practice is B.S.S. International, Inc, at 7777 N University Dr, Tamarac, FL 33321 in Broward County. The practice phone is (954) 726-7773.

Dr. Hammond's primary practice is B.S.S. International, Inc in Tamarac, Florida. Dr. Hammond is also affiliated with Boca Raton Regional Hospital. The medical group on file is Baptist Health Medical Group North. Dmand AI also links Dr. Hammond to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hammond practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hammond's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hammond is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hammond's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Hammond treats.

CMS data shows 1,444 Medicare services from Dr. Hammond across 9 procedure codes in 2024, for 626 Medicare patients. Medicare paid $142,284 for them.

CMS counts 626 Medicare patients who saw Dr. Hammond in 2024. The largest group is 75 to 84, with 294 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hammond's median patient age at 78, with 52% women.

In 2024, Dr. Hammond wrote 1,870 Medicare Part D claims for 397 patients. 96% of them were for generic drugs. CMS names the drug for 1,617 of them, across 36 drugs with 11 or more claims each, at $69,247 in total drug cost. In 2023, CMS named 1,657 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Hammond for performance year 2024, reported through an alternative payment model (APM). Dr. Hammond accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hammond as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Hammond, published from 2020 to 2023. 2023 was the busiest year, with 2. Dr. Hammond has published most often in Cureus. Dr. Hammond's most frequent co-authors are Denis Babici, MD, Angel S. Bayas, MD and Marc Arthur Swerdloff, MD.

CMS Open Payments shows 735 general payments to Dr. Hammond from 68 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. ACADIA Pharmaceuticals Inc paid the most, $1,130. It also lists 9 research payments totaling $709 in 2018.

Dmand AI lists 3 awards for Dr. Hammond, most recently Super Doc in 2013.

Dr. Hammond graduated from New York University School of Medicine in 1975.

Dr. Hammond is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.